Home › Despite downgrades, analysts still expect near tripling of Valeant's share price
 

Keywords :   


Despite downgrades, analysts still expect near tripling of Valeant's share price

2016-03-17 16:03:34| Biotech - Topix.net

Subscribe to Globe Unlimited now and get up-to-the minute insights on developing market news with Inside the Market! Valeant Pharmaceuticals International Inc. left even its most supportive analysts with a sense of unease after a conference call this week to review reduced profit targets. "How do we get comfortable that Valeant is able to execute and deliver for shareholders?" Shibani Malhotra, analyst with Nomura Securities, asked chief executive Michael Pearson on the call Tuesday.

Tags: price share expect analysts

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news
»
05.11Tropical Storm Rafael Graphics
05.11Tropical Storm Rafael Wind Speed Probabilities Number 7
05.11Tropical Storm Rafael Public Advisory Number 7
05.11Summary for Tropical Storm Rafael (AT3/AL182024)
05.11Tropical Storm Rafael Forecast Advisory Number 7
05.11Boeing strike ends as workers back 38% pay rise deal
05.11Tropical Storm Rafael Public Advisory Number 6A
05.11Summary for Tropical Storm Rafael (AT3/AL182024)
More »